John Lesnick

2.2k total citations
12 papers, 846 citations indexed

About

John Lesnick is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, John Lesnick has authored 12 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 1 paper in Organic Chemistry. Recurrent topics in John Lesnick's work include Receptor Mechanisms and Signaling (8 papers), Neuroscience and Neuropharmacology Research (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). John Lesnick is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Neuroscience and Neuropharmacology Research (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). John Lesnick collaborates with scholars based in United States and Switzerland. John Lesnick's co-authors include Jeffrey R. Jasper, David E. Clarke, Anthony Ford, Donald V. Daniels, David J. Chang, Joel R. Gever, Richard M. Eglen, David R. Blue, Thomas K. H. Chang and Douglas W. Bonhaus and has published in prestigious journals such as FEBS Letters, Annals of the New York Academy of Sciences and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

John Lesnick

12 papers receiving 799 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Lesnick United States 9 530 330 197 185 151 12 846
Donald V. Daniels United States 12 497 0.9× 315 1.0× 171 0.9× 142 0.8× 138 0.9× 19 764
Hitomi Shinoura Japan 14 434 0.8× 225 0.7× 101 0.5× 117 0.6× 135 0.9× 21 702
Massimo Parlani Italy 18 363 0.7× 406 1.2× 326 1.7× 34 0.2× 226 1.5× 43 954
Agnès Choppin United States 14 434 0.8× 294 0.9× 307 1.6× 62 0.3× 126 0.8× 26 830
Carlo Alberto Maggi Italy 23 616 1.2× 714 2.2× 147 0.7× 32 0.2× 447 3.0× 35 1.2k
C.J. Daly United Kingdom 17 483 0.9× 242 0.7× 18 0.1× 56 0.3× 256 1.7× 40 760
Manoj C. Rodrigo United States 12 588 1.1× 159 0.5× 18 0.1× 110 0.6× 134 0.9× 19 1.0k
Toru Fujikawa Japan 9 374 0.7× 240 0.7× 200 1.0× 32 0.2× 120 0.8× 13 709
Alberto Meli Italy 12 186 0.4× 297 0.9× 171 0.9× 66 0.4× 198 1.3× 16 601
Paz Recio Spain 14 79 0.1× 81 0.2× 192 1.0× 122 0.7× 171 1.1× 36 493

Countries citing papers authored by John Lesnick

Since Specialization
Citations

This map shows the geographic impact of John Lesnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lesnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lesnick more than expected).

Fields of papers citing papers by John Lesnick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lesnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lesnick. The network helps show where John Lesnick may publish in the future.

Co-authorship network of co-authors of John Lesnick

This figure shows the co-authorship network connecting the top 25 collaborators of John Lesnick. A scholar is included among the top collaborators of John Lesnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Lesnick. John Lesnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lesnick, John, et al.. (2019). Whole Genome Sequencing of Microbial Communities for Scaling Microbiome and Metagenomic Studies. Journal of Biomolecular Techniques JBT. 30. 1 indexed citations
2.
Heffron, Timothy P., Chudi Ndubaku, Laurent Salphati, et al.. (2016). Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR. ACS Medicinal Chemistry Letters. 7(4). 351–356. 76 indexed citations
3.
Lesnick, John, et al.. (2015). Miniaturization of High-Throughput Epigenetic Methyltransferase Assays with Acoustic Liquid Handling. SLAS TECHNOLOGY. 21(1). 208–216. 9 indexed citations
4.
Staben, Steven T., Nicole Blaquière, Vickie Tsui, et al.. (2012). Cis-Amide isosteric replacement in thienobenzoxepin inhibitors of PI3-kinase. Bioorganic & Medicinal Chemistry Letters. 23(3). 897–901. 5 indexed citations
5.
Raddatz, Rita, Venkatesalu Bakthavachalam, John Lesnick, et al.. (2000). Imidazoline-Binding Domains on Monoamine Oxidase B and Subpopulations of Enzyme. Journal of Pharmacology and Experimental Therapeutics. 292(3). 1135–1145. 25 indexed citations
6.
Daniels, Donald V., Joel R. Gever, Jeffrey R. Jasper, et al.. (1999). Human cloned α1A-adrenoceptor isoforms display α1L-adrenoceptor pharmacology in functional studies. European Journal of Pharmacology. 370(3). 337–343. 68 indexed citations
7.
Lesnick, John, Jeffrey R. Jasper, Sara MacLennan, et al.. (1999). Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild‐type and D79N α2A‐adrenoceptor transgenic mice. British Journal of Pharmacology. 126(6). 1522–1530. 63 indexed citations
8.
Zhu, Qianqian, John Lesnick, Jeffrey R. Jasper, et al.. (1999). α2A‐Adrenoceptors, Not I1‐Imidazoline Receptors, Mediate the Hypotensive Effects of Rilmenidine and Moxonidine in Conscious Mice: In Vivo and In Vitro Studies. Annals of the New York Academy of Sciences. 881(1). 287–289. 2 indexed citations
9.
Chang, David J., Thomas K. H. Chang, Felix H. Salazar, et al.. (1998). Molecular cloning, genomic characterization and expression of novel human α1A‐adrenoceptor isoforms. FEBS Letters. 422(2). 279–283. 73 indexed citations
10.
Jasper, Jeffrey R., John Lesnick, Leon Chang, et al.. (1998). Ligand Efficacy and Potency at Recombinant α2 Adrenergic Receptors. Biochemical Pharmacology. 55(7). 1035–1043. 144 indexed citations
11.
Ford, Anthony, Donald V. Daniels, David J. Chang, et al.. (1997). Pharmacological pleiotropism of the human recombinant α1A‐adrenoceptor: implications for α1‐adrenoceptor classification. British Journal of Pharmacology. 121(6). 1127–1135. 200 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald V. Daniels Breakdown of academic impact, for papers by Hitomi Shinoura Breakdown of academic impact, for papers by Massimo Parlani Breakdown of academic impact, for papers by Agnès Choppin Breakdown of academic impact, for papers by Carlo Alberto Maggi Breakdown of academic impact, for papers by C.J. Daly Breakdown of academic impact, for papers by Manoj C. Rodrigo Breakdown of academic impact, for papers by Toru Fujikawa Breakdown of academic impact, for papers by Alberto Meli Breakdown of academic impact, for papers by Paz Recio
Rankless by CCL
2026